EN IT

Phio Pharmaceuticals climbs 1% but stays trapped: the decline loses steam without turning

Phio Pharmaceuticals (PHIO) technical analysis: the sell signal enters its 13th week, CMF turns positive again but volume swings back to sellers while the price stays trapped near recent lows.

Phio Pharmaceuticals climbs 1% but stays trapped: the decline loses steam without turning
Sell signal, week 13: CMF stays positive, but volume swings back to sellers
Phio Pharmaceuticals climbs 1% but stays trapped: the decline loses steam without turning
July 24, 2026
Sell signal, week 13: CMF stays positive, but volume swings back to sellers
Our view last week
Phio Pharmaceuticals' double bottom in the 0.96 area is holding for a third straight week, with the intermediate rebound now up to 16%. This week's technical picture on Phio shows the clearest signal coming from the money flow: CMF has flipped positive after weeks in negative territory, with 88% of volume on the buy side. The ADX, though, keeps sliding week after week: the decline is losing conviction. The sell signal stays active, with the short up 13.45%.
This week's summary
Phio Pharmaceuticals' money flow stays positive for a second straight week, but sellers take back the edge on volume this time: 70% of trading swung to the sell side, versus 88% on the buy side seven days ago. The ADX keeps sliding: the decline keeps losing conviction. The double bottom in the 0.96 area holds for a fourth week, with the short up 12.61%.
Ongoing decline ·14th week from start ·US stocks ·T2 ·📅 Earnings · Aug 6 ★ See Gold version →
IQS Phase
64
ordinary
Signal Strength
2
decline fading out
Sizing
MINIMUM
Ranking
#138 / 141
US stocks
Trade P&L %
+12.61%
from signal to today
Chart · Weekly — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
How to read this pageA visual guide to the post, card by card
Rank position

ranks 138th among the 141 sell signals for US stocks in our ranking, with a signal strength of 2 out of 100.

Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein positive regime
Performanceweekly +0.92% · monthly +6.01%

PHIO belongs to the health care sector (reference ETF XLV). The sector is classified in positive regime according to our weekly reading.

Become a Platinum client to read the full technical analysis, the trading plan and the detailed entry, take-profit and stop-loss levels. ★ PLATINUM
restricted Platinum content
Share WhatsApp Telegram Gmail LinkedIn